Table 2.
Patient responses to PCS12 and MCS12 at baseline and follow-up surveys
| Mean | 95% CI | p value | |
|---|---|---|---|
| PCS12 | |||
| Before | 40.4 | 39.4–41.4 | <0.0001 |
| After | 36.8 | 35.7–37.8 | |
| MCS12 | |||
| Before | 52.3 | 51.4–53.2 | 0.0003 |
| After | 49.9 | 48.9–50.9 | |
CI = confidence interval; MCS12 = composites scores for mental health; PCS12 = composites scores for physical health.
PCS12 and MCS12 were significantly lower at follow-up (after bladder cancer) than at baseline (before bladder cancer).